| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Robin Howard W serves as a President &CEO at NKTR. Across recent SEC filings that breaks down to 0 buys and 97 sells. Those positions are worth an estimated $5.8M at current prices.
Historically, Robin Howard W's trades have earned a middling insider score of 58/100 across 25 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -8.4%.
The biggest single holding is NKTR (~$5.8M) as President &CEO. The recent filings there lean toward selling, a net 3,591,677 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2017 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 87,500 | $12.35 | $1,080,625.00 | -33.0% | |
| Dec 7, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 87,500 | $12.24 | $1,071,000.00 | -41.6% | |
| Nov 17, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 93,458 | $13.88 | $1,296,798.68 | -27.5% | |
| Oct 4, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 87,500 | $17.06 | $1,492,750.00 | -40.4% | |
| Sep 1, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 87,500 | $17.83 | $1,560,125.00 | -40.4% | |
| Aug 16, 2016 | NKTR Nektar Therapeutics | President &CEO | Sell | 11,817 | $17.56 | $207,506.52 | -8.4% | |
| May 17, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 2,170 | $13.58 | $29,468.60 | -11.4% | |
| Feb 17, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 2,147 | $11.92 | $25,592.24 | -13.7% | |
| Feb 10, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 66,666 | $11.49 | $765,992.34 | -87.0% | |
| Jan 19, 2016 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 66,667 | $14.12 | $941,338.04 | -87.0% |